Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX-02 in Nephropathic Cystinosis Patients
| Image |  |
|---|---|
| Description | scientific article published on 23 December 2020 |
| Author/s |
author: Paul Goodyer |
| Publication date | December 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |